ClearPoint Neuro, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)

Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)	1 Months Ended		3 Months Ended		12 Months Ended
	Jul. 26, 2016	Jul. 21, 2016	Mar. 31, 2017 USD ($) Number	Mar. 31, 2016 Number	Dec. 31, 2016 USD ($) Number
Description of the reverse stock split	A 1-for-40 reverse stock split of its issued common stock on July 26, 2016.	A 1-for-40 reverse stock split of its issued common stock on July 26, 2016.
FDIC insured limit \| $			$ 0
Allowance for doubtful accounts \| $			$ 31,000		$ 25,000
Minimum [Member]
Term of service agreements (in years)			1 year
Maximum [Member]
Term of service agreements (in years)			3 years
Customer Concentration Risk [Member] \| Accounts Receivable [Member]
Number of major customers \| Number			2		3
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Customer A [Member]
Percentage of concentration risk			20.00%		20.00%
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Customer B [Member]
Percentage of concentration risk			13.00%		13.00%
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Customer C [Member]
Percentage of concentration risk					10.00%
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Other Customers with Total Accounts Receivable over Threshold [Member]
Percentage of concentration risk			9.00%		9.00%
Customer Concentration Risk [Member] \| Sales Revenue, Net [Member]
Number of major customers \| Number			1	1
Customer Concentration Risk [Member] \| Sales Revenue, Net [Member] \| Customer A [Member]
Percentage of concentration risk			12.00%	11.00%
Customer Concentration Risk [Member] \| Sales Revenue, Net [Member] \| Other Customers with Total Product Revenues Over Threshold [Member]
Percentage of concentration risk			9.00%	9.00%